Literature DB >> 22673513

MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7.

Dongsheng Sun1, Jun Zhang, Jianhong Xie, Wei Wei, Mantao Chen, Xiang Zhao.   

Abstract

Cellular cholesterol levels are tightly regulated and represent a balance of cholesterol uptake, endogenous synthesis and efflux. Although the classic transcriptional regulations of cholesterol metabolism by liver X receptors (LXRs) have been well studied, the potential effects of LXR-responsive microRNAs (miRNAs) still need to be unveiled. Here, we describe that miR-26, an LXR-suppressed miRNA, inhibits the expression of the ATP-binding cassette transporter A1 (ABCA1) and ADP-ribosylation factor-like 7 (ARL7), two LXR target genes which play critical roles in cholesterol efflux. These findings have not only figured out an alternative mechanism for LXR regulation, but also provided a potential therapeutic target for cholesterol metabolic disorders.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22673513     DOI: 10.1016/j.febslet.2012.03.068

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  57 in total

Review 1.  MicroRNA control of high-density lipoprotein metabolism and function.

Authors:  Katey J Rayner; Kathryn J Moore
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

2.  Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein.

Authors:  Kasey C Vickers; Kathryn J Moore
Journal:  Circ Res       Date:  2013-11-08       Impact factor: 17.367

Review 3.  The emerging role of epigenetics in cardiovascular disease.

Authors:  Charbel Abi Khalil
Journal:  Ther Adv Chronic Dis       Date:  2014-07       Impact factor: 5.091

Review 4.  Implications for MicroRNA involvement in the prognosis and treatment of atherosclerosis.

Authors:  Samira Tabaei; Seyyedeh Samaneh Tabaee
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

Review 5.  A big role for small RNAs in HDL homeostasis.

Authors:  Mireille Ouimet; Kathryn J Moore
Journal:  J Lipid Res       Date:  2013-03-18       Impact factor: 5.922

Review 6.  From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport.

Authors:  Alberto Dávalos; Carlos Fernández-Hernando
Journal:  Pharmacol Res       Date:  2013-02-19       Impact factor: 7.658

Review 7.  From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis.

Authors:  D D'Ardes; F Santilli; M T Guagnano; M Bucci; F Cipollone
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-01-10

Review 8.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

9.  MicroRNA Levels as Prognostic Markers for the Differentiation Potential of Human Mesenchymal Stromal Cell Donors.

Authors:  Nicole Georgi; Hanna Taipaleenmaki; Christian C Raiss; Nathalie Groen; Karolina Janaeczek Portalska; Clemens van Blitterswijk; Jan de Boer; Janine N Post; Andre J van Wijnen; Marcel Karperien
Journal:  Stem Cells Dev       Date:  2015-06-17       Impact factor: 3.272

Review 10.  MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.

Authors:  Neetu Sud; Jennifer Taher; Qiaozhu Su
Journal:  Drug Dev Res       Date:  2015-08-19       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.